Connect with us

Raising Them Right

BREAKING: Is DEI Officially Dying Off?

Published

on

I find it disheartening to see U.S. companies veering away from the diversity, equity, and inclusion (DEI) initiatives they once embraced following the unrest sparked by the George Floyd riots in 2020.

According to a study conducted by DE&I consulting firm Paradigm, which analyzed anonymous data from 148 companies, there’s a noticeable trend of reducing DEI budgets and scaling back on strategies aimed at fostering inclusivity.

The primary catalyst for this shift stems from the U.S. Supreme Court’s June ruling, deeming affirmative action unconstitutional. Consequently, companies that previously provided preferential hiring treatment based on race and sexual orientation are now facing a surge of lawsuits.

What’s concerning is that this trend isn’t limited to DE&I alone. Environmental Social Governance (ESG) initiatives, which have served as a mechanism for the left to influence companies toward embracing climate and social agendas for the past decade, are also waning in corporate America. The heightened awareness and backlash from consumers have prompted companies to step back from these initiatives.

In the grand scheme of things, DE&I and ESG may not be completely abandoned, but witnessing this pullback is refreshing.

Continue Reading
Advertisement

Raising Them Right

BREAKING: You Won’t Believe What Liberals Trying To Push On Your Kids NOW

Published

on

In the latest installment of the widely watched Netflix children’s series CoComelon Lane, viewers are introduced to Nico, a young lad adorned in feminine attire, gracefully performing ballet routines to the delight of his two fathers.

As the top-rated children’s show on Netflix, catering to the preschool demographic, CoComelon Lane has certainly made its mark. However, this particular episode seems to take a leap into the realm of progressive family ideals. Nico’s transgender identity, coupled with the presence of gay dads and an interracial couple, forms a noteworthy trifecta in Netflix’s pursuit of diversity and inclusion.

Let’s engage in a candid discussion about what some may label as the “Woke Olympics.” Setting aside concerns about potential child indoctrination, it’s intriguing to observe the streaming giant’s commitment to showcasing its vision of a modern, progressive family. With a transgender boy and gay dads prominently featured, this episode earns a commendable 8 out of 10 woke stars in the eyes of those evaluating societal representation.

It’s worth pondering whether Netflix will further diversify its portrayal by introducing a character who is a disabled lesbian with he/him pronouns. If such an addition were to materialize, it could potentially elevate the streaming platform’s woke score to a perfect 10 out of 10.

Critics argue that this instance is part of a broader trend in Hollywood, wherein popular children’s brands are leveraged to promote specific ideological viewpoints. Over recent years, shows like SpongeBob SquarePants, Blues Clues, Proud Family, and Scooby-Doo have been cited for incorporating radical notions surrounding gender, sexuality, and race into their narratives, prompting discussions about the appropriateness of such themes for young audiences.

Continue Reading

Raising Them Right

BREAKING: Are Trans Activists BULLYING People Now?!

Published

on

Short answer: yeah.

Watch:

Continue Reading

Raising Them Right

Paxton vs. Pfizer Showdown: The Battle for Truth in COVID-19 Vaccine Controversy

Published

on

In a surprising turn of events, Texas Attorney General Ken Paxton has taken legal action against pharmaceutical giant Pfizer, accusing the company of misrepresenting the efficacy of its widely-used COVID-19 vaccine and suppressing public discourse surrounding it. The lawsuit, filed under the Texas Deceptive Trade Practices Act, claims that Pfizer utilized an unreliable method, known as “relative risk reduction,” to assert a 95% effectiveness for its vaccine. As the legal battle unfolds, a closer look reveals intriguing details about the controversy and its potential impact on public perception.

Paxton contends that Pfizer’s use of the “relative risk reduction” assessment method to claim a 95% effectiveness is a violation of the Texas Deceptive Trade Practices Act. This method, Paxton argues, could unduly influence patients and leave them vulnerable to making poor health decisions. The lawsuit further points to data suggesting that certain areas in the U.S. reported more COVID-linked deaths among vaccinated individuals than those who opted not to receive the vaccine.

In response to the allegations, Pfizer staunchly defends its claims, asserting that the representations made about its COVID-19 vaccine are accurate and science-based. Despite the legal scrutiny, the pharmaceutical giant has had a remarkably profitable year, with revenue soaring to an astounding $37.7 billion in 2022. This financial success adds an intriguing layer to the ongoing controversy, raising questions about the intersection of public health, corporate interests, and legal accountability.

Pfizer’s tremendous financial success in 2022, raking in $37.7 billion from its COVID-19 vaccine, spotlights the economic stakes in the pharmaceutical industry. The juxtaposition of legal action and financial prosperity prompts reflection on the broader dynamics at play. As the legal battle unfolds, the pharmaceutical industry’s influence on public health policies and the economic implications of vaccine distribution are under increased scrutiny.

Despite facing challenges from state legislators attempting to remove him, Attorney General Ken Paxton remains steadfast in his pursuit of justice. Paxton initiated the investigation into vaccine manufacturers earlier in the year, demonstrating his commitment to protecting citizens who may have been misled and harmed by Pfizer’s actions. The legal proceedings will likely shed light on the intricate balance between public health, corporate responsibility, and the role of government oversight.

The legal clash between Texas Attorney General Ken Paxton and Pfizer unveils a complex web of allegations, financial interests, and public health concerns. As the legal battle progresses, it will be crucial to monitor how this controversy shapes public perception, influences future vaccine developments, and establishes precedents for corporate accountability. The intersection of science, commerce, and governance is at the heart of this unfolding narrative, emphasizing the need for transparency and ethical practices in the pharmaceutical industry.

Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.